GSK plc (GSK) shareholders
Close on Nov 18, 2026Market cap $104.82BP/E 13.2Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 369,576,114 | 8.90% | 13G (passive) amendment | Dec 31, 2024 |
| Abigail P. Johnson Joint filing with FMR LLC (5.80%) | 234,936,061 | 5.80% | 13G (passive) | Mar 31, 2026 |
| GSK plc | 1,983,025 | 9.50% | 13D (active) amendment | Nov 12, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of GSK | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| FMR LLC | 64,961,641 | – | $3.41B | −2,700,005 | 0.15% |
| Dodge & Cox | 48,197,514 | – | $2.53B | −10,465,460 | 1.32% |
| Fisher Asset Management, LLC | 35,722,792 | – | $1.87B | +1,200,429 | 0.56% |
| Primecap Management Co/Ca/ | 25,182,068 | – | $1.32B | −22,470 | 0.78% |
| Wellington Management Group Llp | 11,396,249 | – | $597.39M | −321,364 | 0.10% |
| JTC Employer Solutions Trustee Ltd | 8,592,987 | – | $450.32M | −449,402 | 36.11% |
| Morgan Stanley | 7,657,562 | – | $401.41M | −3,373,089 | 0.02% |
| Royal Bank of Canada | 7,588,928 | – | $397.81M | +82,142 | 0.06% |
| Price T Rowe Associates Inc /Md/ | 6,923,642 | – | $362.94M | −399,191 | 0.04% |
| Acadian Asset Management LLC | 6,660,434 | – | $349.11M | −5,136,651 | 0.41% |
| Goldman Sachs Group Inc | 6,371,442 | – | $333.99M | −3,217,672 | 0.03% |
| State Street Corp | 5,959,115 | – | $315.14M | −39,371 | 0.01% |
| Mondrian Investment Partners LTD | 4,910,830 | – | $257.43M | −76,563 | 3.97% |
| Bank Of Montreal /Can/ | 4,042,863 | – | $211.93M | −596,936 | 0.07% |
| BlackRock, Inc. | 3,620,294 | – | $189.78M | +69,390 | 0.00% |
| Grantham, Mayo, Van Otterloo & Co. LLC | 3,599,521 | – | $188.69M | +76,955 | 0.42% |
| Hotchkis & Wiley Capital Management LLC | 3,413,574 | – | $178.94M | −68,480 | 0.52% |
| Equity Investment Corp | 3,269,765 | – | $171.40M | +48,730 | 3.27% |
| UBS Group AG | 2,806,205 | – | $147.10M | +721,970 | 0.02% |
| Connor, Clark & Lunn Investment Management Ltd. | 2,767,591 | – | $145.08M | −49,854 | 0.27% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,036 | 347M | 108 / 376 | 340 / 81 | 17M | 44M |
| Q1 2026 | 1,031 | 374M | 139 / 315 | 382 / 83 | 31M | 52M |
| Q4 2025 | 993 | 398M | 179 / 309 | 338 / 61 | 41M | 31M |
| Q3 2025 | 892 | 388M | 100 / 323 | 307 / 79 | 27M | 25M |
| Q2 2025 | 887 | 386M | 111 / 367 | 252 / 62 | 44M | 17M |
| Q1 2025 | 854 | 365M | 91 / 330 | 277 / 67 | 52M | 28M |
| Q4 2024 | 844 | 341M | 110 / 284 | 317 / 149 | 68M | 35M |
| Q3 2024 | 894 | 309M | 91 / 304 | 319 / 69 | 24M | 26M |
| Q2 2024 | 879 | 312M | 78 / 307 | 304 / 87 | 25M | 49M |
| Q1 2024 | 901 | 336M | 98 / 326 | 298 / 79 | 56M | 19M |
| Q4 2023 | 889 | 300M | 127 / 270 | 341 / 63 | 37M | 22M |
| Q3 2023 | 842 | 285M | 100 / 303 | 268 / 70 | 26M | 17M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
152 funds held GSK in Q2 2026, 3% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of GSK | Value | % of fund | As of |
|---|---|---|---|---|---|
| Dodge & Cox Stock Fund | 35,573,787 | – | $1.86B | 1.58% | Jun 30, 2026 |
| Vanguard Primecap Fund | 18,172,650 | – | $952.61M | 0.99% | Jun 30, 2026 |
| Vanguard Wellington Fund | 9,662,999 | – | $488.37M | 0.39% | May 31, 2026 |
| Strategic Advisers Fidelity U.S. Total Stock Fund | 7,787,127 | – | $393.56M | 0.16% | May 31, 2026 |
| Fidelity Series Large Cap Stock Fund | 4,579,628 | – | $240.06M | 0.83% | Jun 30, 2026 |
| Fidelity Series Value Discovery Fund | 4,136,200 | – | $213.80M | 1.21% | Jul 31, 2026 |
| Dodge & Cox Balanced Fund | 3,600,595 | – | $188.74M | 1.28% | Jun 30, 2026 |
| Vanguard Primecap Core Fund | 3,549,080 | – | $186.04M | 1.03% | Jun 30, 2026 |
| Fidelity Growth and Income Portfolio | 3,439,475 | – | $177.79M | 1.19% | Jul 31, 2026 |
| Fidelity Equity Dividend Income Fund | 2,665,900 | – | $134.73M | 1.67% | May 31, 2026 |
| T. Rowe Price International Value Equity Fund | 2,639,571 | – | $136.44M | 0.80% | Jul 31, 2026 |
| Select Pharmaceuticals Portfolio | 2,425,160 | – | $122.57M | 8.17% | May 31, 2026 |
| Bridge Builder Large Cap Value Fund | 1,876,800 | – | $98.38M | 0.34% | Jun 30, 2026 |
| Fidelity Large Cap Stock Fund | 1,708,759 | – | $88.33M | 0.83% | Jul 31, 2026 |
| Vanguard Windsor Ii Fund | 1,597,215 | – | $82.56M | 0.12% | Jul 31, 2026 |
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of GSK's stock actually held short. Settlement fails (shares not delivered on time) peaked at 518,186 shares on Oct 9, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Martinez Maria E Officer | Aug 20, 2026 | 44,397 | $2.31M | Aug 20, 2026 | Share Value Plan Vesting |
Congress trades
40 trades in GSK reported by 10 members of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| Lisa McClain MI09 · spouse | Sold | Oct 31, 2025 | $1K–15K | Nov 21, 2025 |
| Lisa McClain MI09 · spouse | Sold | Oct 30, 2025 | $1K–15K | Nov 21, 2025 |
| Lisa McClain MI09 · spouse | Bought | Oct 30, 2025 | $1K–15K | Nov 21, 2025 |
| Valerie Hoyle OR04 · spouse | Sold | Sep 23, 2025 | $1K–15K | Oct 10, 2025 |
| Lisa McClain MI09 · spouse | Bought | Aug 4, 2025 | $1K–15K | Sep 12, 2025 |
| Robert B. Aderholt AL04 | Sold | Jul 28, 2025 | $1K–15K | Sep 10, 2025 |
| Lisa McClain MI09 · spouse | Sold | Jun 24, 2025 | $1K–15K | Aug 13, 2025 50 days late |
| Lisa McClain MI09 · spouse | Bought | Jun 17, 2025 | $1K–15K | Aug 13, 2025 57 days late |
| Bruce Westerman AR04 | Sold | Apr 21, 2025 | $1K–15K | May 12, 2025 |
| Bruce Westerman AR04 | Bought | Mar 3, 2025 | $1K–15K | Apr 16, 2025 |
| Marjorie Taylor Mrs Greene GA14 | Bought | Nov 25, 2024 | $1K–15K | Nov 27, 2024 |
| Valerie Hoyle OR04 · spouse | Bought | Nov 18, 2024 | $1K–15K | Sep 12, 2025 298 days late |
| Daniel Goldman NY10 | Sold | Jul 10, 2023 | $15K–50K | Aug 13, 2023 |
| Virginia Foxx NC05 · joint account | Sold | Mar 1, 2023 | $50K–100K | Apr 4, 2023 |
| Virginia Foxx NC05 · joint account | Bought | Aug 16, 2022 | $1K–15K | Sep 8, 2022 |
| Virginia Foxx NC05 · joint account | Bought | Aug 10, 2022 | $15K–50K | Sep 8, 2022 |
| Virginia Foxx NC05 · joint account | Bought | Aug 9, 2022 | $1K–15K | Sep 8, 2022 |
| Virginia Foxx NC05 · joint account | Bought | Aug 5, 2022 | $15K–50K | Sep 8, 2022 |
| Virginia Foxx NC05 · joint account | Sold (part) | Jul 12, 2022 | $100K–250K | Aug 5, 2022 |
| Virginia Foxx NC05 · joint account | Bought | Jul 6, 2022 | $1K–15K | Aug 5, 2022 |
| Virginia Foxx NC05 · joint account | Bought | Apr 8, 2022 | $1K–15K | May 4, 2022 |
| Virginia Foxx NC05 · joint account | Bought | Feb 22, 2022 | $1K–15K | Mar 7, 2022 |
| John Rutherford FL05 | Sold | Feb 17, 2022 | $1K–15K | Mar 16, 2022 |
| Virginia Foxx NC05 · joint account | Bought | Jan 14, 2022 | $1K–15K | Feb 4, 2022 |
| Virginia Foxx NC05 · joint account | Bought | Oct 8, 2021 | $1K–15K | Nov 2, 2021 |
| Virginia Foxx NC05 · joint account | Bought | Jul 9, 2021 | $1K–15K | Aug 2, 2021 |
| Katherine M. Clark MA05 · spouse | Sold | Jun 4, 2021 | $1K–15K | Aug 15, 2021 72 days late |
| Katherine M. Clark MA05 · spouse | Sold | Jun 4, 2021 | $1K–15K | Aug 15, 2021 72 days late |
| Virginia Foxx NC05 · joint account | Bought | Apr 9, 2021 | $1K–15K | May 5, 2021 |
| Virginia Foxx NC05 · joint account | Bought | Jan 15, 2021 | $1K–15K | Feb 1, 2021 |
| Katherine M. Clark MA05 · spouse | Bought | Nov 5, 2020 | $1K–15K | Dec 28, 2020 53 days late |
| Katherine M. Clark MA05 · spouse | Bought | Nov 5, 2020 | $1K–15K | Dec 28, 2020 53 days late |
| Katherine M. Clark MA05 · spouse | Sold | Oct 22, 2020 | $1K–15K | Dec 3, 2020 |
| Katherine M. Clark MA05 · spouse | Sold | Oct 22, 2020 | $1K–15K | Dec 3, 2020 |
| Virginia Foxx NC05 · joint account | Bought | Oct 9, 2020 | $1K–15K | Nov 6, 2020 |
| Virginia Foxx NC05 · joint account | Bought | Jul 10, 2020 | $1K–15K | Aug 10, 2020 |
| Virginia Foxx NC05 · joint account | Bought | Apr 13, 2020 | $15K | May 4, 2020 |
| Greg Gianforte MT00 · joint account | Bought | Mar 18, 2020 | $50K | Apr 7, 2020 |
| Katherine M. Clark MA05 · spouse | Bought | Mar 2, 2020 | $1K–15K | Apr 20, 2020 49 days late |
| Katherine M. Clark MA05 · spouse | Bought | Mar 2, 2020 | $1K–15K | Apr 20, 2020 49 days late |
See a number that looks wrong?